Medicine

WHO: Trial Sudan Ebolavirus Vaccine Marks Historical Milestone

The vaccine for the Sudan ebolavirus is one of the three candidates recommended for the trial by an independent WHO expert panel.

MBT Desk

The World Health Organization says the arrival of one of three trial Ebola vaccines in Uganda Thursday “marks a historical milestone in the global capacity to respond to outbreaks.”

The 1,200 doses of the Sudan ebolavirus vaccine arrived “just 79 days after the outbreak was declared on 20 September,” the WHO said.

“Uganda is showing that life-saving research can be promptly organized in the midst of an outbreak,” said Dr. Jane Ruth Aceng Acero, Uganda’s minister of health.

In contrast, WHO said that “To start Phase 3 trials in Guinea during the West Africa Ebola outbreak in 2015, it was 7 months from declaration to arrival of vaccines. This was a great achievement and set historical records at the time.”

The vaccine for the Sudan ebolavirus is one of the three candidates recommended for the trial by an independent WHO expert panel. The other two will be added to the trial when the doses arrive. (HN/VOA)

Hurry up! Join the Medical Internship 3.0 at MedBound!

HHS Eliminates CDC Staff Who Made Sure Birth Control Is Safe for Women at Risk

Feds Investigate Hospitals Over Religious Exemptions From Gender-Affirming Care

India Facing a Shortage of Family Physicians – Here's Why

Simple Muscle Ultrasound Can Detect Early Prediabetes

Mount Sinai Researchers Use Wearable Technology to Explore the Link Between IBD and Sleep Disruption